Retrospective analysis indicated that high PDE5 expression significantly correlated with increased overall survival of patients, identifying this enzyme as a favourable prognostic marker for GBM, which negatively affects cell invasiveness and survival [253]. The gene discussed is PDE5A; the disease is glioblastoma.